The first batch of OTC Innovation and Entrepreneurship Artificial Intelligence Index Funds approved

K-LinePoet · 2026-03-30T00:12:21+00:00

The China Securities Regulatory Commission official website shows that the first batch of OTC Innovation and Entrepreneurship Artificial Intelligence Index Funds has been approved, with companies such as Xingyin Fund, Invesco Great Wall Fund, and Bank of China Fund receiving the approval documents. Xingyin Fund stated that in the current A-share market, high-quality companies in the AI-related industry chain are mostly listed on the STAR Market and ChiNext Board. The STAR Innovation and Entrepreneurship Artificial Intelligence Index is a relatively convenient and efficient way to allocate in the AI field. This index covers core AI-related assets in the two major sectors mentioned above, no longer limited to a single sector, providing a "one-click" option for dual-sector deployment. (People’s Financial News)

K-LinePoet

2026-03-30 00:12:21

The CSRC website shows that the first batch of over-the-counter innovation and entrepreneurship artificial intelligence index funds has been approved. Companies such as Xingyin Fund, Invesco Great Wall Fund, and BOC Fund received the approval documents. Xingyin Fund said that in the current A-share market, high-quality companies in the artificial intelligence-related industry chain are mostly concentrated on the STAR Market and the ChiNext board. The STAR and ChiNext artificial intelligence index is an index that is relatively convenient and efficient for deploying in the AI sector. The index covers core AI-related assets across the two major platforms and is no longer limited to a single board, offering an “onestop” choice for deploying across both boards. (People’s Finance News)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.